Czech National Bank Increases Stock Holdings in Revvity, Inc. (NYSE:RVTY)

Czech National Bank raised its position in shares of Revvity, Inc. (NYSE:RVTY) by 0.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,713 shares of the company’s stock after acquiring an additional 99 shares during the period. Czech National Bank’s holdings in Revvity were worth $2,280,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in RVTY. Parkside Financial Bank & Trust purchased a new stake in Revvity during the fourth quarter valued at about $25,000. Gladius Capital Management LP grew its position in Revvity by 84.1% during the third quarter. Gladius Capital Management LP now owns 232 shares of the company’s stock valued at $26,000 after acquiring an additional 106 shares during the period. CENTRAL TRUST Co purchased a new stake in Revvity during the fourth quarter valued at about $27,000. Benjamin F. Edwards & Company Inc. acquired a new position in shares of Revvity during the fourth quarter worth about $27,000. Finally, ORG Partners LLC acquired a new position in shares of Revvity during the fourth quarter worth about $32,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have commented on RVTY shares. Robert W. Baird boosted their price objective on Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a research note on Tuesday, April 30th. TD Cowen boosted their price objective on Revvity from $123.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, April 30th. Finally, Jefferies Financial Group started coverage on Revvity in a research note on Monday, June 3rd. They set a “hold” rating and a $115.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Revvity currently has a consensus rating of “Moderate Buy” and a consensus target price of $117.92.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 4,000 shares of the business’s stock in a transaction dated Friday, June 7th. The stock was sold at an average price of $110.46, for a total value of $441,840.00. Following the completion of the sale, the insider now directly owns 36,900 shares of the company’s stock, valued at $4,075,974. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.60% of the stock is owned by corporate insiders.

Revvity Trading Up 0.4 %

NYSE:RVTY opened at $107.98 on Friday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.92 and a current ratio of 2.23. Revvity, Inc. has a one year low of $79.50 and a one year high of $131.96. The business’s 50-day simple moving average is $106.70 and its 200 day simple moving average is $105.79. The stock has a market cap of $13.32 billion, a price-to-earnings ratio of 89.24, a price-to-earnings-growth ratio of 2.80 and a beta of 1.08.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Monday, April 29th. The company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.04. The firm had revenue of $649.90 million during the quarter, compared to analyst estimates of $646.83 million. Revvity had a return on equity of 7.37% and a net margin of 5.49%. Revvity’s quarterly revenue was down 3.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.01 earnings per share. As a group, sell-side analysts predict that Revvity, Inc. will post 4.65 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.26%. The ex-dividend date of this dividend is Friday, July 19th. Revvity’s dividend payout ratio is currently 23.14%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.